Neuropace, Inc. NPCE Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s total cost of revenue?
- Neuropace, Inc. (NPCE) reported total cost of revenue of $4.02M in Q1 2026.
- How has Neuropace, Inc.'s total cost of revenue changed year-over-year?
- Neuropace, Inc.'s total cost of revenue decreased by 22.4% year-over-year, from $5.18M to $4.02M.
- What is the long-term trend for Neuropace, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s total cost of revenue has grown at a 18.0% compound annual growth rate (CAGR), from $11.75M to $22.77M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.